Literature DB >> 9637273

A histomorphometric study of haematological disorders with respect to marrow fibrosis and osteosclerosis.

L W Poulsen1, F Melsen, K Bendix.   

Abstract

A retrospective investigation of 75 EDTA-decalcified Jamshidi biopsies collected over a 2-year period at Aarhus University Hospital was performed. The biopsies originated from 75 patients suffering from idiopathic myelofibrosis, other chronic myeloproliferative disorders, or other conditions with known associations with bone marrow fibrosis. The relative volumes of trabecular and woven bone, as well as haematopoietic and non-haematopoietic tissue, were estimated histomorphometrically. The degree of fibrosis was estimated semiquantitatively. Finally, the thickness of trabecular osteons was estimated from the number of lamellae by counting. Patients with idiopathic myelofibrosis had statistically significantly more bone tissue than the other groups of patients. The osteosclerosis was primarily due to woven bone. Larger cancellous osteons also suggested a positive balance in bone remodelling. The amount of bone tissue showed furthermore a statistically significant increase through the groups of polycythaemia vera, essential thrombocythaemia, chronic myelogenous leukaemia and idiopathic myelofibrosis. Parallel to the increase in the amount of bone, an increase in the degree of marrow fibrosis was detected. The positive correlation between the amount of bone and the degree of marrow fibrosis was statistically highly significant (p=0.0008).

Entities:  

Mesh:

Year:  1998        PMID: 9637273     DOI: 10.1111/j.1699-0463.1998.tb01377.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  5 in total

1.  Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers.

Authors:  Sarah Farmer; Hanne Vestergaard; Stinus Hansen; Vikram Vinod Shanbhogue; Vikram Vinod Shanbhoque; Claudia Irene Stahlberg; Anne Pernille Hermann; Henrik Frederiksen
Journal:  Int J Hematol       Date:  2015-05-05       Impact factor: 2.490

2.  Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study.

Authors:  Carolin J Teman; Andrew R Wilson; Sherrie L Perkins; Kimberly Hickman; Josef T Prchal; Mohamed E Salama
Journal:  Leuk Res       Date:  2010-01-31       Impact factor: 3.156

Review 3.  Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.

Authors:  Aikaterini Karagianni; Katya Ravid
Journal:  Blood       Date:  2022-05-26       Impact factor: 25.476

4.  TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche.

Authors:  Juo-Chin Yao; Karolyn A Oetjen; Tianjiao Wang; Haoliang Xu; Grazia Abou-Ezzi; Joseph R Krambs; Salil Uttarwar; Eric J Duncavage; Daniel C Link
Journal:  J Clin Invest       Date:  2022-06-01       Impact factor: 19.456

5.  Bone metabolism during interferon-alpha treatment of essential thrombocythemia.

Authors:  Rajko Kusec; Vesna Kusec; Bettina Gisslinger; Wolfgang Woloszczuk; Heinz Gisslinger
Journal:  Wien Klin Wochenschr       Date:  2004-01-31       Impact factor: 2.275

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.